Evidence map›Paper›PMID 34501099›Full record

ArticleMaterials (Basel, Switzerland)2021

Co

Krzysztof Marycz, Eliza Turlej, Katarzyna Kornicka-Garbowska, Emilia Zachanowicz, Anna Tomaszewska, Magdalena Kulpa-Greszta, Robert Pązik

Open access · goldAbstract read
In one paragraph

Article in Materials (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.4field-weighted citation impact, top 43% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 5 citations in OpenAlex.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 1 country.

Krzysztof MaryczDepartment of Experimental Biology, Wrocław University of Environmental and Life Sciences, ul. CK. Norwida 27B, 50-375 Wrocław, Poland.
Eliza TurlejDepartment of Experimental Biology, Wrocław University of Environmental and Life Sciences, ul. CK. Norwida 27B, 50-375 Wrocław, Poland.
Katarzyna Kornicka-GarbowskaDepartment of Experimental Biology, Wrocław University of Environmental and Life Sciences, ul. CK. Norwida 27B, 50-375 Wrocław, Poland.
Emilia ZachanowiczPolymer Engineering and Technology Division, Wroclaw University of Technology, ul. Wyb. Wyspiańskiego 27, 50-370 Wrocław, Poland.ORCID 0000-0003-3195-6307
Anna TomaszewskaDepartment of Biotechnology, Institute of Biology and Biotechnology, College of Natural Sciences, University of Rzeszow, Pigonia 1, 35-310 Rzeszow, Poland.ORCID 0000-0003-2548-0568
Magdalena Kulpa-GresztaDepartment of Biotechnology, Institute of Biology and Biotechnology, College of Natural Sciences, University of Rzeszow, Pigonia 1, 35-310 Rzeszow, Poland.
Robert PązikDepartment of Biotechnology, Institute of Biology and Biotechnology, College of Natural Sciences, University of Rzeszow, Pigonia 1, 35-310 Rzeszow, Poland.ORCID 0000-0002-4662-6688
Wrocław University of Environmental and Life Sciences · PLUniversity of Rzeszów · PLRzeszów University of Technology · PLWrocław University of Science and Technology · PL

Funding

Narodowe Centrum Nauki 2017/26/M/NZ5/01184
6 · The paper itself

Abstract

The prevalence of osteoporosis in recent years is rapidly increasing. For this reason, there is an urgent need to develop bone substitutes and composites able to enhance the regeneration of damaged tissues which meet the patients' needs. In the case of osteoporosis, personalized, tailored materials should enhance the impaired healing process and restore the balance between osteoblast and osteoclast activity. In this study, we fabricated a novel hybrid material (Co

Indexed as

apoptosisCo0.5Mn0.5Fe2O4integrinsmagnetic fieldmicroRNAsosteoclastsosteoporosisPMMApre-osteoblasts

Identifiers

PMID34501099
PMCPMC8434396
OpenAlexW3196581020

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.